TRAW

TRAW Traws Pharma, Inc.

Traws Pharma, Inc. · NASDAQ
Market Closed
0.18
▼ ⁦-23.91%⁩ (-0.06)
Post-market0.17-5.71% (-0.01)
Market Cap$2.7M
Beta1.66
52w Low52w High
0.173.23
Last Week
⁦-30.28%⁩
Last Month
⁦-52.28%⁩
Last 3 Months
⁦-68.75%⁩
Last Year
⁦-91.71%⁩
Open on chart
Premium content
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$700 / yr
Monthly plan
$99 / mo
Analyst Estimates

The company reports in USD. Forecast amounts use the data provider’s units.

Quarterly estimates

Fiscal period end

Last refreshed

EPS Estimate
-0.45
Range -0.45 – -0.45
Analysts 1
Revenue Estimate
0
Range 0 – 0
Analysts 0
Fiscal period end

Last refreshed

EPS Estimate
-0.95
Range -0.95 – -0.95
Analysts 1
Revenue Estimate
0
Range 0 – 0
Analysts 0
Fiscal period end

Last refreshed

EPS Estimate
-0.46
Range -0.46 – -0.46
Analysts 1
Revenue Estimate
0
Range 0 – 0
Analysts 0
Fiscal period end

Last refreshed

EPS Estimate
-1.16
Range -1.16 – -1.16
Analysts 1
Revenue Estimate
0
Range 0 – 0
Analysts 0

Annual estimates

Fiscal period end

Last refreshed

EPS Estimate
-1.20
Range -1.23 – -1.17
Analysts 1
Revenue Estimate
300K
Range 300K – 300K
Analysts 2
Fiscal period end

Last refreshed

EPS Estimate
-1.235
Range -1.8724 – -0.5876
Analysts 1
Revenue Estimate
13.1M
Range 13.1M – 13.1M
Analysts 1
Fiscal period end

Last refreshed

EPS Estimate
-0.60
Range -0.60 – -0.60
Analysts 1
Revenue Estimate
55.4M
Range 55.4M – 55.4M
Analysts 1
1 analyst
Premium content
Which listings have analyst coverage?

EL7 refreshes analyst ratings and price targets for active company listings on Nasdaq, the New York Stock Exchange and NYSE American, including US-listed depositary receipts. Funds (including ETFs and mutual funds), OTC listings and listings on other exchanges are outside this coverage. Some eligible listings may have no published target or analyst call in the past 12 months.

EL7 checks for new ratings several times on weekdays, refreshes consensus targets on weekdays and updates monthly rating history once a month.

Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
  • P/E (TTM)
    —
    —
  • Forward P/E
    —
    —
  • EV / EBITDA
    —
    —
  • FCF Yield
    Outlier
    —
  • Revenue Growth YoY
    —
    —
  • EPS Growth YoY
    —
    —
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    -0.02x
    0.00x1.99x
    Net cash
  • Dividend Yield
    Pays no dividend
    —
  • Payout Ratio
    Pays no dividend
    —
  • Altman Z-Score
    —
    —
Financial Analysis
Related News

Frequently Asked Questions

What is Traws Pharma, Inc. stock?▼

Traws Pharma, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Traws Pharma, Inc.?▼

You can buy Traws Pharma, Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Traws Pharma, Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Traws Pharma, Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Traws Pharma, Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.